1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Indoco Remedies Secures EU GMP Certification for Goa Sterile Facility

24 Jul 2025
Admin
News Article

Indoco Remedies Secures EU GMP Certification for Goa Sterile Facility

Indoco Remedies Ltd., a fully integrated and research-driven pharmaceutical company, has received the EU Good Manufacturing Practices (GMP) Compliance Certificate from the European Health Authorities. This certification pertains to its sterile drug product manufacturing site—Goa Plant II, located at L32, L33, and L34 in the Verna Industrial Estate, South Goa-403722.

Certification Significance

The EU GMP certificate affirms that Goa Plant II complies with the stringent manufacturing and quality standards required by the European regulatory framework. It confirms that the site has passed inspection and adheres to internationally accepted manufacturing practices for sterile drug products.

Leadership Commentary

Aditi Panandikar, Managing Director of Indoco Remedies Ltd., emphasized the strategic value of this milestone:

“This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies. We remain fully committed to adhering to cGMP standards and consistently delivering quality products to customers and patients worldwide.”

Company Snapshot

Global footprint: Indoco has a well-established presence in regulated and semi-regulated markets worldwide.
Financial scale: The company reports a turnover of approximately US$ 180 million.
Human capital: With over 6,000 employees, Indoco’s workforce includes more than 400 scientists and field staff, underscoring its deep R&D capabilities and commercial reach.

This certification adds further credibility to Indoco’s sterile manufacturing operations and strengthens its position as a reliable partner for global pharmaceutical supply.